Jason Rieser, MD
Family Medicine · Indianapolis, INNPI 1922001494
Payments from drug & device makers
Across 243 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Boehringer Ingelheim$659
- Novo Nordisk$597
- GSK$584
- Pfizer$246
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$192
- plus $937 from 19 others
What the payments were for
- Food & beverage$4,328100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 59 | $1,114 |
| Boehringer Ingelheim | 41 | $659 |
| Novo Nordisk | 29 | $597 |
| GSK | 36 | $584 |
| Pfizer | 17 | $246 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $192 |
| Biohaven Pharmaceuticals, Inc. | 8 | $156 |
| Gilead | 7 | $116 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $92 |
| Dynavax Technologies Corporation | 4 | $78 |
| AstraZeneca | 4 | $72 |
| Ultragenyx Pharmaceutical Inc. | 3 | $57 |
| Merck | 3 | $51 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Abbott | 2 | $37 |
| Exact Sciences | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Cranial Technologies, Inc | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Alkermes, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Aquestive Therapeutics, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $14 |
| Bayer | 1 | $13 |
How this compares
$4,328 in reported general payments places this provider in the 85th percentile of 2,709 family medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 38 | $40,930 |
| Gabapentin | 18 | $351 |
| Atorvastatin Calcium | 50 | $264 |
| Amlodipine Besylate | 20 | $259 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $237 |
| Omeprazole | 21 | $210 |
| Lisinopril | 28 | $208 |
| Metformin Hcl | 15 | $192 |
| Metformin Hcl ErMetformin Hcl | 16 | $173 |
| Losartan Potassium | 23 | $102 |
| Pantoprazole Sodium | 15 | $92 |
| Levothyroxine Sodium | 27 | $86 |
| Simvastatin | 13 | $83 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 14 | $73 |
| Sertraline Hcl | 13 | $60 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Indianapolis
- Blair BrengleIndianapolis$10.6M
- Steven SmithIndianapolis$2.5M
- Richard TannerIndianapolis$1.6M
- Richard FeldmanIndianapolis$476K
- Joe BanksIndianapolis$294K
- Jakoda SniderIndianapolis$107K
- Robert ClutterIndianapolis$77K
- Gaylen KeltonIndianapolis$42K
- Daniela LoboIndianapolis$38K
- Haihong MaoIndianapolis$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.